Study of Bleeding With Extended Administration of an Oral Contraceptive
Phase 2
Completed
- Conditions
- Contraception
- First Posted Date
- 2006-06-20
- Last Posted Date
- 2008-05-08
- Lead Sponsor
- Warner Chilcott
- Target Recruit Count
- 207
- Registration Number
- NCT00338052
- Locations
- 🇺🇸
Warner Chilcott Investigational Site, Seattle, Washington, United States
Study of Transdermal Testosterone Patches in Surgically Menopausal Women With Low Libido
Phase 3
Completed
- Conditions
- Hypoactive Sexual Desire Disorder
- Interventions
- Drug: PlaceboDrug: Testosterone Transdermal System
- First Posted Date
- 2006-05-29
- Last Posted Date
- 2013-04-17
- Lead Sponsor
- Warner Chilcott
- Target Recruit Count
- 562
- Registration Number
- NCT00331123
- Locations
- 🇨🇦
Research Site, Quebec, Canada
Study of Transdermal Testosterone Patches in Surgically Menopausal Women With Low Libido
Phase 3
Completed
- Conditions
- Hypoactive Sexual Desire Disorder
- Interventions
- Drug: placebo patchDrug: Testosterone Transdermal System
- First Posted Date
- 2006-05-29
- Last Posted Date
- 2013-04-17
- Lead Sponsor
- Warner Chilcott
- Target Recruit Count
- 533
- Registration Number
- NCT00331214
- Locations
- 🇨🇦
Research Site, Kingston, Ontario, Canada
A Study of Asacol Absorption, Metabolism and Excretion in Children and Adolescents With Ulcerative Colitis.
- First Posted Date
- 2005-11-16
- Last Posted Date
- 2013-04-17
- Lead Sponsor
- Warner Chilcott
- Target Recruit Count
- 34
- Registration Number
- NCT00254618
- Locations
- 🇺🇸
Research Site, Seattle, Washington, United States
A Study of Monthly Risedronate for Osteoporosis
- First Posted Date
- 2005-11-01
- Last Posted Date
- 2013-04-22
- Lead Sponsor
- Warner Chilcott
- Target Recruit Count
- 1294
- Registration Number
- NCT00247273
- Locations
- 🇪🇸
Research Site, Madrid, Spain
Study of Transdermal Testosterone Patches in Menopausal Women With Low Libido
Phase 3
Completed
- Conditions
- Hypoactive Sexual Desire Disorder
- Interventions
- Drug: Placebo patchDrug: Testosterone (transdermal patches)
- First Posted Date
- 2005-08-18
- Last Posted Date
- 2013-04-17
- Lead Sponsor
- Warner Chilcott
- Target Recruit Count
- 814
- Registration Number
- NCT00131495
- Locations
- 🇦🇺
Monash Medical School, The Alfred Hospital, Prahran, Victoria, Australia
Safety and Efficacy of Risedronate in the Treatment of Osteogenesis Imperfecta in Children
Phase 3
Completed
- Conditions
- Osteogenesis Imperfecta
- Interventions
- Drug: risedronate sodium (Actonel)Drug: Placebo
- First Posted Date
- 2005-03-21
- Last Posted Date
- 2013-04-22
- Lead Sponsor
- Warner Chilcott
- Target Recruit Count
- 143
- Registration Number
- NCT00106028
- Locations
- 🇩🇪
Klinikum und Poliklinik für Kinderheilkunde der Universität zu Köln, Koln, Germany
🇧🇪Cliniques Universitaires Saint Luc, Bruxelles, Belgium
🇦🇺The Children's Hospital at Westmead, Westmead, New South Wales, Australia
Safety and Efficacy of Two Different Doses of Asacol in the Treatment of Moderately Active Ulcerative Colitis
Phase 3
Completed
- Conditions
- Ulcerative Colitis
- Interventions
- First Posted Date
- 2003-11-17
- Last Posted Date
- 2015-06-29
- Lead Sponsor
- Warner Chilcott
- Target Recruit Count
- 386
- Registration Number
- NCT00073021
- Locations
- 🇺🇸
University of Chicago Medical Center, Chicago, Illinois, United States
🇺🇸Louisiana Research Center, Shreveport, Louisiana, United States
🇺🇸Long Island Clinical Research Associates, Great Neck, New York, United States
© Copyright 2025. All Rights Reserved by MedPath